Compare LENZ & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | NAK |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 852.0M | 922.7M |
| IPO Year | 2021 | 2002 |
| Metric | LENZ | NAK |
|---|---|---|
| Price | $17.35 | $2.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $56.25 | $2.50 |
| AVG Volume (30 Days) | 1.1M | ★ 6.9M |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $204.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.70 | $0.45 |
| 52 Week High | $50.40 | $2.98 |
| Indicator | LENZ | NAK |
|---|---|---|
| Relative Strength Index (RSI) | 23.37 | 58.94 |
| Support Level | $15.70 | $1.91 |
| Resistance Level | $29.02 | $2.09 |
| Average True Range (ATR) | 2.37 | 0.15 |
| MACD | -0.91 | 0.03 |
| Stochastic Oscillator | 9.76 | 76.12 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.